Fulcrum Therapeutics Inc (FULC)
EBITDA Growth
-16.15%
Quarterly · Period ending:
FULC EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-16.15%period ending
Latest reported-16.15%period ending
FULC Quarterly EBITDA YoY % (-414.62% → -16.15%)
Year-over-year change
High-resolution chart · PNG
FULC ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -16.1515% | |
| -7.2304% | |
| -23.3842% | |
| 15.1802% | |
| -130.3881% | |
| 34.4398% | |
| 33.1945% | |
| 3.3722% | |
| 340.2869% | |
| -8.9952% | |
| 11.5682% | |
| -0.8892% | |
| 30.4785% | |
| 4.6432% | |
| -19.9318% | |
| -15.8332% | |
| -75.9802% | |
| -54.4526% | |
| -34.0624% | |
| -8.3396% | |
| -23.4533% | |
| 9.9523% | |
| -9.2925% | |
| -12.4924% | |
| -18.4206% | |
| 50.2846% | |
| -78.4946% | |
| -91.0998% | |
| -69.762% | |
| -414.616% |